首页> 美国卫生研究院文献>Journal of Vascular Surgery Cases and Innovative Techniques >Safety and efficacy of a modified HeRO dialysis device in achieving early graft cannulation: A single-institution experience
【2h】

Safety and efficacy of a modified HeRO dialysis device in achieving early graft cannulation: A single-institution experience

机译:改进的HeRO透析设备在实现早期插管中的安全性和有效性:单机构经验

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Hemodialysis Reliable Outflow (HeRO) grafts (Merit Medical Systems, Inc, South Jordan, Utah) provide a means for access in catheter-dependent hemodialysis patients but typically require several weeks for tissue incorporation. Modifying the HeRO graft with an ACUSEAL graft (W. L. Gore & Associates, Newark, Del) can allow immediate cannulation, thus reducing catheter dependence time and its associated complications. A retrospective review of patients at our institution from 2013 to 2016 who underwent placement of a modified HeRO dialysis system with ACUSEAL graft was performed. Complications and outcomes were analyzed, with patency rates and hours to successful cannulation being major end points. Modified HeRO grafts were successfully placed in 10 catheter-dependent patients. Postoperative complications included two thromboses and one hematoma. At 6 months of follow-up, mean time to graft cannulation was 33.7 hours, with 100% success; the primary and secondary patency rates were 70% and 90%, respectively. Our modification allows an accelerated use of the HeRO system, reducing catheter dependence time with acceptable postoperative complications and patency rates.
机译:血液透析可靠流出(HeRO)移植物(Merit Medical Systems,Inc,南犹他州犹他州)为依赖导管的血液透析患者提供了一种进入途径,但通常需要几周的时间才能纳入组织。用ACUSEAL移植物(W. L. Gore&Associates,纽瓦克,特拉华州)修饰HeRO移植物可以立即插管,从而减少了导管依赖时间及其相关并发症。回顾性分析了我院2013年至2016年接受改良的HERO透析系统并使用ACUSEAL移植物的患者。分析并发症和结局,以通畅率和成功插管时间为主要终点。改良的HeRO移植物成功植入10例依赖导管的患者中。术后并发症包括2例血栓形成和1例血肿。随访6个月时,平均插管时间为33.7小时,成功率为100%;初级和次级通畅率分别为70%和90%。我们的改进可以加快HeRO系统的使用,减少导管依赖时间,并具有可接受的术后并发症和通畅率。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号